GLP-1 therapies are booming
US$ 22.12
glp-1 and surgery risk Pulmonary Aspiration Warning for (Glucagon-like peptide-1) Diabetes Weight Loss Meds North American Chapter of IFSO
Description
A second unknown is safety
These finding suggested that endotoxin, frequently released in the ESRD setting, may consistently cause damage to the mesothelial layer, potentially leading to PD failure
Over time, untreated OSA increases the risk of hypertension, heart disease, stroke, type 2 diabetes, and cognitive decline
Case report: amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide
Cell 185 , 11301142.e1111 (2022)
